N/A
N=61
Outcomes in Rotator Cuff Repair Using Graft Reinforcement
Rotator Cuff Tear
Bottom Line
View on ClinicalTrials.gov: NCT01025037 ↗Enrolled (actual)
61
Serious AEs
1.6%
Results posted
Jan 2015
Primary outcome: Primary: American Shoulder and Elbow Score (ASES) — 48.7; 69.4; 79.9; 85.4 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Conexa Reconstructive Tissue Matrix (Device)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- Stryker Trauma and Extremities
- Primary completion
- Feb 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY American Shoulder and Elbow Score (ASES) |
48.7; 69.4; 79.9; 85.4; 90.4 | — |
| PRIMARY Adjusted Constant-Murley Score |
45.4; 62.9; 68.7; 71.7 | — |
| PRIMARY Simple Shoulder Test (SST) |
5.0; 6.4; 8.7; 9.9; 10.6 | — |
| SECONDARY Rotator Cuff Re-tear Evaluation |
18.5; 16.9; 32.2; 33.9 | — |
| SECONDARY Isometric Strength |
34.4; 61.9; 83.0; 78.6 | — |
Summary
The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.
Eligibility Criteria
Inclusion Criteria
The patient:
- is an adult male or female between the ages of 40-70 years old;
- has repairable primary large retracted two-tendon rotator cuff tears measuring from 3 cm to 5 cm;
- requires surgical repair of single rotator cuff (i.e. one limb);
- has movement of the non-operative arm defined as shoulder elevation of equal to or greater than 90 degrees and is able to perform postoperative exercises;
- is able to return for all scheduled and required study visits;
- is able to provide written informed consent for study participation.
Exclusion Criteria
The patient:
- has irreparable large rotator cuff tears that are found intra-operatively. Note: irreparable is defined by the inability to approximate the tendon to the tuberosity without tension;
- has a rotator cuff tear 5cm (measured intra-operatively);
- has a rotator cuff tear where the subscapularis tendon is disrupted/requires repair;
- has grade 3 or 4 fatty infiltration of the rotator cuff;
- has had prior surgical repair to the affected shoulder;
- is American Society of Anesthesiologists (ASA) Class 4 or 5 (See Appendix I);
- is a tobacco user; unless tobacco free 6 months prior to surgery and willing to remain tobacco free for the duration of the study.
- has lower limb injuries requiring walking assist devices such as crutches and walkers;
- has a known collagen disorder, including systemic lupus erythematous (SLE), rheumatoid arthritis (RA), polymyositis, scleroderma, ankylosing spondylitis, dermatomyositis, osteogenesis imperfecta or the inherited disorders of Sjogren, Larsen, Raynaud, Ehlers-Danlos or Marfan syndrome.
- has obstacles that pose an inordinately high surgical risk, in the judgment of the certified surgeon;
- has co-morbid factors which predispose to postoperative infection, such as insulin dependent diabetes, chronic steroid use, malnourishment, cancer, or co-existent infection;
- has a history of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction;
- is enrolled or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial;
- has any of the conditions identified within the labeled contraindications, i.e. sensitivity to porcine derived products or polysorbate.
- has an inability to have a closed MRI conducted.
- needs a re-operation for a re-tear of the rotator cuff.
Data sourced from ClinicalTrials.gov (NCT01025037). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.